Xeris Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Highlights

Go back to Xeris Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Highlights
(NASDAQ: XERS) Delayed: 6.95 +0.05 (0.72%)
Previous Close $6.90    52 Week High
Open $7.03    52 Week Low
Day High $7.06    P/E N/A 
Day Low $6.93    EPS
Volume 2,398,786